Document is current
Any future updates will be listed below
-
Authors
Salazar Saez, Raquel
Zorrilla, Miriam
Sánchez, Rosa
Cebollero, Ana
Manrique, Isabel
Martín, Alfonso
de Ávila, Leticia
Lacalle-Emborujo, Alejandra
Martin-Rodriguez, Samuel
Bernardo-González, Iván
Alonso, Martina
-
Funding
Funding for this research was provided by:
AstraZeneca Farmacéutica Spain (none, none, none, none, none, none, none, none, none, none, none)
- License Information
-
More Information
Article History
Received: 5 July 2024
Accepted: 7 October 2024
First Online: 22 October 2024
Declarations
:
: The study was approved by the Hospital San Pedro ethics committee “Comité de Ética de investigación con medicamentos en La Rioja” (Ref. CEImLAR P.I. 570). All tested individuals provided a signed informed consent following the appropriate genetic counselling.
: Not applicable.
: Alejandra Lacalle-Emborujo has received speaker honorarium from Brystol Myers Squibb, Ipsen and Janssen. The remaining authors declare that they have no competing interests.
